Added benefit of aclidinium bromide is not proven
The drug aclidinium bromide (trade names Eklira, Bretaris) has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease (COPD). The German Institute for Quality ...
Medications
Jan 30, 2013 |
not rated yet |
0
Bone marrow biopsy adds little to PET/CT staging of Hodgkin's
(HealthDay)—For patients with treatment-naive Hodgkin's lymphoma (HL) staged using [18F]fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT), routine bone marrow biopsy (BMB) has little or no ther ...
Cancer
Nov 15, 2012 |
not rated yet |
0
Starchy, high carbohydrate diet associated with recurrence of colon cancer
Colon cancer survivors whose diet is heavy in complex sugars and carbohydrate-rich foods are far more likely to have a recurrence of the disease than are patients who eat a better balance of foods, a new study by Dana-Farber ...
Cancer
Nov 07, 2012 |
not rated yet |
0
|
Marital status, race increase survival rate significantly for Stage III non-small cell lung cancer patients
A study of survival data for Stage III, non-small cell lung cancer (NSCLC) patients at the University of Maryland's Greenebaum Cancer Center in Baltimore indicates that marital status and race can significantly impact patient ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Brain radiation after lung cancer treatment reduces risk of cancer spreading
Stage III non-small cell lung cancer (NSCLC) patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial irradiation (PCI); ...
Cancer
Sep 06, 2012 |
not rated yet |
0
New study reveals racial disparities in voice box-preserving cancer treatment
A new epidemiological study led by UC Davis researchers reveals significant racial disparities in the use of non-surgical larynx-preservation therapy for locally advanced laryngeal cancer.
Cancer
Jul 16, 2012 |
not rated yet |
0
Researchers discover a DNA marker that indicates if ovarian cancer treatment will be successful
Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered that blood can help determine the best treatment plan for patients with ovarian cancer. More specifically, ...
Cancer
Apr 03, 2012 |
4 / 5 (1) |
0
Adding drug to chemotherapy following colon cancer surgery does not improve disease-free survival
Adding the drug cetuximab to a regimen of drugs used for the treatment of patients following surgery for stage III colon cancer did not result in improved disease-free survival, according to a study in the April 4 issue of ...
Cancer
Apr 03, 2012 |
not rated yet |
0
Financial hardship common among colon cancer patients
(HealthDay) -- Nearly 40 percent of patients undergoing adjuvant chemotherapy for stage III colon cancer experience financial hardship, even if they have health insurance coverage, according to research published ...
Cancer
Mar 13, 2012 |
not rated yet |
0
Complementary meds used by 17 percent of elderly with cancer
(HealthDay) -- The prevalence of older people with cancer using complementary medications as they start a chemotherapy regimen is 17 percent, and is associated with less advanced disease and higher functional ...
Cancer
Mar 02, 2012 |
not rated yet |
0
Mammography-detected breast cancer in 40-49 year-olds has better prognosis
Based on a study of nearly 2,000 breast cancer patients, researchers at the Swedish Cancer Institute in Seattle say that, in women between the ages of 40 and 49, breast cancers detected by mammography have a better prognosis. ...
Cancer
Feb 22, 2012 |
not rated yet |
0
Study showed oxaliplatin improved colon cancer patient survival
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published ...
Cancer
Jan 20, 2012 |
not rated yet |
0
Targeted therapy extends progression-free survival of patients with advanced ovarian cancer
Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic ...
Cancer
Dec 28, 2011 |
not rated yet |
0
|
Circulating tumor cells not linked to survival in newly diagnosed inflammatory breast cancer
The presence of circulating tumor cells in the blood appears to have no relationship to survival in women who have just been diagnosed with inflammatory breast cancer, according to new research from Fox Chase Cancer Center. ...
Inflammatory disorders
Dec 09, 2011 |
not rated yet |
0
Higher radiation dose does not help lung cancer patients live longer
A higher dose of radiation (74 Gy) does not improve overall survival for non-small cell lung cancer that has spread to the lymph nodes, compared to the standard radiation dose (60 Gy), according to an interim analysis of ...
Cancer
Oct 03, 2011 |
not rated yet |
0
